Rural Pharmacy and Prescription Drugs – Resources
Selected recent or important resources focusing on Rural Pharmacy and Prescription Drugs.
Pharmacy-Related Syringe Access Barriers: An Audit of Oregon Community Pharmacies
Examines barriers to purchasing over-the-counter (OTC) syringes in Oregon pharmacies. Utilizes a telephone audit (secret shopper) methodology to examine 425 pharmacies' willingness to sell OTC syringes by pharmacy type, syringe services program (SSP) availability, overdose rates, and rural versus urban county type.
Author(s): Victor Abreu, Marissa McGinnis, Savannah Justen, et al.
Citation: Harm Reduction Journal, 22, 37
Date: 03/2025
view details
Examines barriers to purchasing over-the-counter (OTC) syringes in Oregon pharmacies. Utilizes a telephone audit (secret shopper) methodology to examine 425 pharmacies' willingness to sell OTC syringes by pharmacy type, syringe services program (SSP) availability, overdose rates, and rural versus urban county type.
Author(s): Victor Abreu, Marissa McGinnis, Savannah Justen, et al.
Citation: Harm Reduction Journal, 22, 37
Date: 03/2025
view details
Vulnerability Index Approach to Identify Pharmacy Deserts and Keystone Pharmacies
Discusses the importance of improving pharmacy access in rural and low-income areas. Utilizes data from the National Council for Prescription Drug Programs (NCPDP) dataQ to examine travel time to nearest pharmacy according to urbanicity. Defines a pharmacy vulnerability index according to this measure and reports on residents in the the contiguous U.S. living in or at risk of living in a pharmacy desert, with comparisons for small rural, large rural, suburban, and urban.
Author(s): Walter S. Mathis, Lucas A. Berenbrok, Peter A. Kahn, et al.
Citation: JAMA Network Open, 8(3)
Date: 03/2025
view details
Discusses the importance of improving pharmacy access in rural and low-income areas. Utilizes data from the National Council for Prescription Drug Programs (NCPDP) dataQ to examine travel time to nearest pharmacy according to urbanicity. Defines a pharmacy vulnerability index according to this measure and reports on residents in the the contiguous U.S. living in or at risk of living in a pharmacy desert, with comparisons for small rural, large rural, suburban, and urban.
Author(s): Walter S. Mathis, Lucas A. Berenbrok, Peter A. Kahn, et al.
Citation: JAMA Network Open, 8(3)
Date: 03/2025
view details
Screening and Referral Programs for Diabetes and Cardiovascular Disease: Can Community Pharmacists Bridge the Care Gap?
Examines the community-based valued-driven care initiative (CVCI) in community pharmacies to evaluate its effectiveness related to screening and referral (S&R) to treat cardiovascular disease (CVD) and diabetes mellitus (DM). Analyzes patient demographics and success rates of CVD and DM S&R in 6 community pharmacies, with both rural and urban locations represented.
Author(s): Melanie Livet, Amber Watson, Shweta Pathak, et al.
Citation: Exploratory Research in Clinical and Social Pharmacy, 17, 100539
Date: 03/2025
view details
Examines the community-based valued-driven care initiative (CVCI) in community pharmacies to evaluate its effectiveness related to screening and referral (S&R) to treat cardiovascular disease (CVD) and diabetes mellitus (DM). Analyzes patient demographics and success rates of CVD and DM S&R in 6 community pharmacies, with both rural and urban locations represented.
Author(s): Melanie Livet, Amber Watson, Shweta Pathak, et al.
Citation: Exploratory Research in Clinical and Social Pharmacy, 17, 100539
Date: 03/2025
view details
Opioid Use Among Rural Medicare Beneficiaries
Examines trends in prescription opioid use among Medicare beneficiaries in rural areas, utilizing 2010-2017 Medicare Current Beneficiary Survey (MCBS) data. Provides data on receipt of opioid prescriptions among community-dwelling and facility-dwelling beneficiaries, associations between prescribing and chronic overlapping pain conditions (COPCs), and prescriptions exceeding CDC guidelines. Includes rural-urban comparisons.
Author(s): Yvonne Jonk, Heidi O'Connor, Karen Pearson, et al.
Date: 01/2025
Sponsoring organization: Maine Rural Health Research Center
view details
Examines trends in prescription opioid use among Medicare beneficiaries in rural areas, utilizing 2010-2017 Medicare Current Beneficiary Survey (MCBS) data. Provides data on receipt of opioid prescriptions among community-dwelling and facility-dwelling beneficiaries, associations between prescribing and chronic overlapping pain conditions (COPCs), and prescriptions exceeding CDC guidelines. Includes rural-urban comparisons.
Author(s): Yvonne Jonk, Heidi O'Connor, Karen Pearson, et al.
Date: 01/2025
Sponsoring organization: Maine Rural Health Research Center
view details
Projecting the Impact of the $2,000 Part D Out-Of-Pocket Cap for Medicare Part D Enrollees with High Prescription Drug Spending
Examines the impact of the Medicare Part D $2,000 cap on out-of-pocket prescription drugs. Provides projected savings according to low-income subsidy (LIS) status, state, and demographic characteristics, including urban, rural-micropolitan, rural-other, or unclassified geographic location.
Date: 01/2025
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Examines the impact of the Medicare Part D $2,000 cap on out-of-pocket prescription drugs. Provides projected savings according to low-income subsidy (LIS) status, state, and demographic characteristics, including urban, rural-micropolitan, rural-other, or unclassified geographic location.
Date: 01/2025
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Innovations in Pharmacy Training and Sustainable Practice to Advance Patient Care: Proceedings of a Workshop (2025)
Proceedings from a workshop convened May 29-30, 2025, exploring opportunities and challenges in pharmacy. Features sections on pharmacy deserts and workforce, financial sustainability, education and training programs, and recommendations for the future. Mentions rural throughout.
Author(s): Roundtable on Quality Care for People with Serious Illness
Date: 2025
Sponsoring organization: Health and Medicine Division (HMD), National Academies of Sciences, Engineering, and Medicine
view details
Proceedings from a workshop convened May 29-30, 2025, exploring opportunities and challenges in pharmacy. Features sections on pharmacy deserts and workforce, financial sustainability, education and training programs, and recommendations for the future. Mentions rural throughout.
Author(s): Roundtable on Quality Care for People with Serious Illness
Date: 2025
Sponsoring organization: Health and Medicine Division (HMD), National Academies of Sciences, Engineering, and Medicine
view details
Buprenorphine Injection Among Rural Persons Who Inject Drugs
Describes buprenorphine use by rural people who inject drugs, using data from the Rural Opioid Initiative, to inform patient-clinician discussions and public health interventions. Features demographics and behavioral characteristics of 2,369 people who were surveyed between 2018-2020.
Author(s): Kaitlin A. Zinsli, Elenore P. Bhatraju, Judith Feinberg, et al.
Citation: JAMA Network Open, 7(12), e2450108
Date: 12/2024
view details
Describes buprenorphine use by rural people who inject drugs, using data from the Rural Opioid Initiative, to inform patient-clinician discussions and public health interventions. Features demographics and behavioral characteristics of 2,369 people who were surveyed between 2018-2020.
Author(s): Kaitlin A. Zinsli, Elenore P. Bhatraju, Judith Feinberg, et al.
Citation: JAMA Network Open, 7(12), e2450108
Date: 12/2024
view details
Pharmacy-Based Preventive Services for Opioid Use Disorder: A Survey of U.S. Pharmacists
Examines pharmacist perceptions related to addressing opioid use disorder (OUD) and substance use disorder (SUD) in their patients. Utilizes online survey data from 1,146 pharmacists to analyze pharmacist concerns about drug use; drug screenings, interventions, and referrals; and commitment and readiness to address OUD and SUD in their patients. Includes breakdowns of pharmacist demographics as well as rurality of pharmacy locations.
Author(s): Li-Tzy Wu, Jacquie King, Kathryn Hefner, et al.
Citation: Addiction Science & Clinical Practice, 19, 88
Date: 12/2024
view details
Examines pharmacist perceptions related to addressing opioid use disorder (OUD) and substance use disorder (SUD) in their patients. Utilizes online survey data from 1,146 pharmacists to analyze pharmacist concerns about drug use; drug screenings, interventions, and referrals; and commitment and readiness to address OUD and SUD in their patients. Includes breakdowns of pharmacist demographics as well as rurality of pharmacy locations.
Author(s): Li-Tzy Wu, Jacquie King, Kathryn Hefner, et al.
Citation: Addiction Science & Clinical Practice, 19, 88
Date: 12/2024
view details
Community Responses and Adaptations Following the Closure of a Rural Pharmacy and Primary Care Facility
Uses interviews with 26 community members to identify the impact of a pharmacy and primary healthcare facility closure in a rural Pennsylvania community. Discusses challenges for vulnerable populations, distance to care, social networks, delayed treatment, emergency medical services, alternative medicine, and more.
Author(s): Hazel Velasco Palacios, Kristina Brant, Danielle Rhubart, Jorden Jackson
Citation: Journal of Rural Health 41(2), e12896
Date: 11/2024
view details
Uses interviews with 26 community members to identify the impact of a pharmacy and primary healthcare facility closure in a rural Pennsylvania community. Discusses challenges for vulnerable populations, distance to care, social networks, delayed treatment, emergency medical services, alternative medicine, and more.
Author(s): Hazel Velasco Palacios, Kristina Brant, Danielle Rhubart, Jorden Jackson
Citation: Journal of Rural Health 41(2), e12896
Date: 11/2024
view details
Ensuring Access To Care: 340B Arrangements with Community and Specialty Pharmacies Improve Access to Care for Underserved Patients
Provides an overview of the 340B Drug Pricing Program, related legislation, benefits to underserved communities, relationship to specialty and community pharmacies, and more. Includes discussion on the value of the 340B program for rural pharmacies.
Date: 09/2024
Sponsoring organization: American Hospital Association
view details
Provides an overview of the 340B Drug Pricing Program, related legislation, benefits to underserved communities, relationship to specialty and community pharmacies, and more. Includes discussion on the value of the 340B program for rural pharmacies.
Date: 09/2024
Sponsoring organization: American Hospital Association
view details
Additional resources are available related to this guide. See the full list of resources by topic for:
Last Updated: 12/22/2025